Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Immunic Inc (IMUX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 31
  • 1 comments

(28% Negative) Immunic, Inc. (IMUX) Reports Net Loss for 2022-06-30

Comment Full text

SpringWorks Therapeutics (SWTX)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 28
  • 1 comments

(75% Positive) SPRINGWORKS THERAPEUTICS, INC. (SWTX) Reports 41% Loss Reduction for 2022-06-30

Comment Full text

Madrigal Pharmaceuticals Inc (MDGL)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 28
  • 1 comments

(47% Neutral) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Reports 108% Loss Increase for 2022-06-30

Comment Full text

Aurinia Pharmaceuticals Inc (AUPH)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 30
  • 1 comments

(28% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports 33% Loss Increase for 2022-06-30

Comment Full text

Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)

  • Event
  • Aug. 04, 2022, 00:00 UTC
  • 35
  • 1 comments

(61% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Reports Net Loss for 2022-06-30

Comment Full text

Pacific Biosciences of California Inc (PACB)

  • Event
  • Aug. 03, 2022, 20:44 UTC
  • 19
  • 1 comments

(10% Negative) Pacific Biosciences of California, Inc. (PACB) Reports Q3 2022 Financial Results

Comment Full text

Poseida Therapeutics (PSTX)

  • Event
  • Aug. 03, 2022, 20:29 UTC
  • 19
  • 1 comments

(10% Negative) Poseida Therapeutics, Inc. (PSTX) Announces Clinical Trial Timeline Adjustment

Comment Full text

Xencor Inc (XNCR)

  • Event
  • Aug. 03, 2022, 20:12 UTC
  • 18
  • 1 comments

(30% Negative) XENCOR, INC. (XNCR) Reports Q3 2022 Financial Results

Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • Event
  • Aug. 03, 2022, 20:12 UTC
  • 19
  • 1 comments

(19% Negative) VANDA PHARMACEUTICALS INC. (VNDA) Reports Q3 2022 Financial Results

Comment Full text

Jazz Pharmaceuticals plc (JAZZ)

  • Event
  • Aug. 03, 2022, 20:07 UTC
  • 17
  • 1 comments

(10% Negative) Jazz Pharmaceuticals plc (JAZZ) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 228
  • 229
  • 230
  • 231
  • 232
  • Next

Search

News categories

  • Technical Exchange News(11448)
  • Event(3168)
  • SEC News(210936)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136424)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin